http://orcid.org/0000-0003-1401-0851
References
- Zhu G, Wang Q. Comparisons between magnetic resonance/ultrasound fusion-guided biopsy and standard biopsy in the diagnosis of prostate cancer: a prospective cohort study. Medicine. 2018;97(36):e11962.
- Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009; 360:1320–1328.
- Pepe P, Garufi A, Priolo G, et al. Prostate cancer detection at repeat biopsy: can pelvic phased-array multiparametric MRI replace saturation biopsy? Anticancer Res. 2013;33(3):1195–1199.
- Okcelik S, Soydan H, Ates F, et al. Evaluation of PCA3 and multiparametric MRI’s: collective benefits before deciding initial prostate biopsy for patients with PSA level between 3-10ng/mL. Int Braz J Urol. 2016;42(3):449–455.
- Isbarn H, Briganti A, De Visschere PJ, et al. Systematic ultrasound-guided saturation and template biopsy of the prostate: indications and advantages of extended sampling. Arch Esp Urol. 2015;68(3):296–306.
- Pepe P, Dibenedetto G, Garufi A, et al. Multiparametric pelvic MRI accuracy in diagnosing clinically significant prostate cancer in the reevaluation of biopsy microfocal tumor. Anticancer Res. 2015;35(1):395–399.
- AlKhateeb SS, AlShammari NA, AlZughaibi MA, et al. The prevalence of urinary tract infection, or urosepsis following transrectal ultrasound-guided prostate biopsy in a subset of the Saudi population and patterns of susceptibility to flouroquinolones. SMJ. 2016;37(8):860–863.
- Hambrock T, Hoeks C, Hulsbergen-van de Kaa C, et al. Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol. 2012;61(1):177–184.
- Oberlin DT, Casalino DD, Miller FH, et al. Dramatic increase in the utilization of multiparametric magnetic resonance imaging for detection and management of prostate cancer. Abdom Radiol. 2017;42(4):1255–1258.
- Li J, Gruschow S, Tewari A. Words of wisdom. Re: prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol. 2012;62(4):731–732.
- Roethke MC, Kuru TH, Schultze S, et al. Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla. Eur Radiol. 2014;24(2):344–352.
- Turkbey B, Rosenkrantz AB, Haider MA, et al. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol. 2019;76(3):340–351.
- Pepe P, Garufi A, Priolo G, et al. Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA < 10 ng/mL? Clin Genitourin Cancer. 2015;13(1):e27–e30.
- Mariotti GC, Falsarella PM, Garcia RG, et al. Incremental diagnostic value of targeted biopsy using mpMRI-TRUS fusion versus 14-fragments prostatic biopsy: a prospective controlled study. Eur Radiol. 2018;28(1):11–16.
- Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012. Eur Radiol. 2012;22(4):746–757.
- Agha RA, Borrelli MR, Vella-Baldacchino M, et al. The STROCSS statement: strengthening the reporting of cohort studies in surgery. Int J Surg. 2017;46:198–202.
- Brembilla G, Dell’Oglio P, Stabile A, et al. Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection. Eur Radiol. 2018;28(5):1969–1976.
- Xylinas E, Yates DR, Renard-Penna R, et al. Role of pelvic phased array magnetic resonance imaging in staging of prostate cancer specifically in patients diagnosed with clinically locally advanced tumours by digital rectal examination. World J Urol. 2013;31(4):881–886.